Mercaptopurine oral - Only for Children Pharmaceuticals
Alternative Names: LoullaLatest Information Update: 16 Jan 2022
At a glance
- Originator Only for Children Pharmaceuticals
- Class Antineoplastics; Purines; Small molecules; Sulfhydryl compounds
- Mechanism of Action Antimetabolites; DNA synthesis inhibitors; Immunosuppressants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Precursor cell lymphoblastic leukaemia-lymphoma
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for phase-I development in Acute-lymphoblastic-leukaemia(In adolescents, In children) in Denmark (PO, Liquid)
- 16 Jul 2016 No recent reports of development identified for phase-I development in Acute-lymphoblastic-leukaemia(In adolescents, In children) in France (PO, Liquid)
- 16 Jul 2016 No recent reports of development identified for phase-I development in Acute-lymphoblastic-leukaemia(In adolescents, In children) in Germany (PO, Liquid)